Potential explanations for these discrepancies in the descriptive analyses of the patient tissue and in cell culture experiments could be the heterogeneity of the relatively small patient cohorts, the molecular diversity of the applied HNSCC cell lines or the different methods that were used for SOX2 down- and upregulation. The gene discussed is SOX2; the disease is head and neck squamous cell carcinoma.